Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1993 Apr;30(4):284–288. doi: 10.1136/jmg.30.4.284

Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.

S Kleiman 1, L Vanagaite 1, J Bernstein 1, G Schwartz 1, N Brand 1, A Elitzur 1, S L Woo 1, Y Shiloh 1
PMCID: PMC1016333  PMID: 8487271

Abstract

Phenylketonuria (PKU) and benign hyperphenylalaninaemia (HPA) result from a variety of mutations in the gene for the hepatic enzyme phenylalanine hydroxylase. PKU has been found in the Israeli population in two variants, classical and atypical. The two are clinically indistinguishable and require treatment with low phenylalanine diet to prevent mental retardation, but show differences in serum phenylalanine levels and in tolerance to this amino acid. Maternal PKU is a syndrome of congenital anomalies and mental retardation that appears in offspring of PKU mothers as a result of fetal exposure to the high phenylalanine level in the maternal blood. We studied a family in which two children with severe, classical PKU and their unaffected brother showed mild signs of maternal PKU. Their mother had no clinical signs of PKU, but the phenylalanine concentration in her serum reached a level that usually characterises PKU patients. This woman represents a rare phenotype, benign atypical PKU. Such 'hidden' PKU in women may lead to maternal PKU in the offspring, similar to overt PKU. Special attention should therefore be paid to women having children with any of the clinical hallmarks of maternal PKU, and to children born to women known to have benign HPA. The mother was also found to be homozygous for a missense mutation at the phenylalanine hydroxylase locus, R261Q, which does not abolish enzymatic activity completely. In two other families, homozygosity for this mutation resulted in atypical PKU in four children. This observation suggests that mutations that do not completely destroy phenylalanine hydroxylase activity may exhibit variable phenotypic expression which is unpredictable. Compound heterozygosity for R261Q and other mutations led in other patients either to classical PKU or to mild benign HPA.

Full text

PDF
284

Images in this article

285Image
on p.285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abadie V., Lyonnet S., Maurin N., Berthelon M., Caillaud C., Giraud F., Mattei J. F., Rey J., Rey F., Munnich A. CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics. 1989 Nov;5(4):936–939. doi: 10.1016/0888-7543(89)90137-7. [DOI] [PubMed] [Google Scholar]
  2. Avigad S., Kleiman S., Weinstein M., Cohen B. E., Schwartz G., Woo S. L., Shiloh Y. Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria. Am J Hum Genet. 1991 Aug;49(2):393–399. [PMC free article] [PubMed] [Google Scholar]
  3. Berthelon M., Caillaud C., Rey F., Labrune P., Melle D., Feingold J., Frézal J., Briard M. L., Farriaux J. P., Guibaud P. Spectrum of phenylketonuria mutations in western Europe and north Africa, and their relation to polymorphic DNA haplotypes at the phenylalanine hydroxylase locus. Hum Genet. 1991 Feb;86(4):355–358. doi: 10.1007/BF00201832. [DOI] [PubMed] [Google Scholar]
  4. Cohen B. E., Szeinberg A., Levine Y., Peled I., Pollack S., Crispin M., Normand M. Phenylketonuria (PKU) in Israel. Monogr Hum Genet. 1978;9:95–101. doi: 10.1159/000401617. [DOI] [PubMed] [Google Scholar]
  5. DiSilvestre D., Koch R., Groffen J. Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes. Am J Hum Genet. 1991 May;48(5):1014–1016. [PMC free article] [PubMed] [Google Scholar]
  6. Dianzani I., Forrest S. M., Camaschella C., Saglio G., Ponzone A., Cotton R. G. Screening for mutations in the phenylalanine hydroxylase gene from Italian patients with phenylketonuria by using the chemical cleavage method: a new splice mutation. Am J Hum Genet. 1991 Mar;48(3):631–635. [PMC free article] [PubMed] [Google Scholar]
  7. Eisensmith R. C., Woo S. L. Phenylketonuria and the phenylalanine hydroxylase gene. Mol Biol Med. 1991 Feb;8(1):3–18. [PubMed] [Google Scholar]
  8. Hanley W. B., Clarke J. T., Schoonheyt W. E. Undiagnosed phenylketonuria in adult women: a hidden public health problem. CMAJ. 1990 Sep 15;143(6):513–516. [PMC free article] [PubMed] [Google Scholar]
  9. Hanley W. B., Clarke J. T., Schoonheyt W. Maternal phenylketonuria (PKU)--a review. Clin Biochem. 1987 Jun;20(3):149–156. doi: 10.1016/s0009-9120(87)80112-1. [DOI] [PubMed] [Google Scholar]
  10. John S. W., Rozen R., Scriver C. R., Laframboise R., Laberge C. Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet. 1990 May;46(5):970–974. [PMC free article] [PubMed] [Google Scholar]
  11. Konecki D. S., Lichter-Konecki U. The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations. Hum Genet. 1991 Aug;87(4):377–388. doi: 10.1007/BF00197152. [DOI] [PubMed] [Google Scholar]
  12. Levy H. L., Lobbregt D., Sansaricq C., Snyderman S. E. Comparison of phenylketonuric and nonphenylketonuric sibs from untreated pregnancies in a mother with phenylketonuria. Am J Med Genet. 1992 Nov 1;44(4):439–442. doi: 10.1002/ajmg.1320440411. [DOI] [PubMed] [Google Scholar]
  13. Levy H. L. Maternal phenylketonuria. Prog Clin Biol Res. 1988;281:227–242. [PubMed] [Google Scholar]
  14. Levy H. L., Waisbren S. E. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus. N Engl J Med. 1983 Nov 24;309(21):1269–1274. doi: 10.1056/NEJM198311243092101. [DOI] [PubMed] [Google Scholar]
  15. Luder A. S., Greene C. L. Maternal phenylketonuria and hyperphenylalaninemia: implications for medical practice in the United States. Am J Obstet Gynecol. 1989 Nov;161(5):1102–1105. doi: 10.1016/0002-9378(89)90642-x. [DOI] [PubMed] [Google Scholar]
  16. Okano Y., Eisensmith R. C., Güttler F., Lichter-Konecki U., Konecki D. S., Trefz F. K., Dasovich M., Wang T., Henriksen K., Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991 May 2;324(18):1232–1238. doi: 10.1056/NEJM199105023241802. [DOI] [PubMed] [Google Scholar]
  17. Okano Y., Wang T., Eisensmith R. C., Güttler F., Woo S. L. Recurrent mutation in the human phenylalanine hydroxylase gene. Am J Hum Genet. 1990 May;46(5):919–924. [PMC free article] [PubMed] [Google Scholar]
  18. Okano Y., Wang T., Eisensmith R. C., Longhi R., Riva E., Giovannini M., Cerone R., Romano C., Woo S. L. Phenylketonuria missense mutations in the Mediterranean. Genomics. 1991 Jan;9(1):96–103. doi: 10.1016/0888-7543(91)90225-4. [DOI] [PubMed] [Google Scholar]
  19. Okano Y., Wang T., Eisensmith R. C., Steinmann B., Gitzelmann R., Woo S. L. Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet. 1990 Jan;46(1):18–25. [PMC free article] [PubMed] [Google Scholar]
  20. Primrose D. A. Phenylketonuria with normal intelligence. J Ment Defic Res. 1983 Dec;27(Pt 4):239–246. doi: 10.1111/j.1365-2788.1983.tb00296.x. [DOI] [PubMed] [Google Scholar]
  21. Rouse B., Lockhart L., Matalon R., Azen C., Koch R., Hanley W., Levy H., dela Cruz F., Friedman E. Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. J Inherit Metab Dis. 1990;13(3):289–291. doi: 10.1007/BF01799376. [DOI] [PubMed] [Google Scholar]
  22. Smith I., Glossop J., Beasley M. Fetal damage due to maternal phenylketonuria: effects of dietary treatment and maternal phenylalanine concentrations around the time of conception (an interim report from the UK Phenylketonuria Register). J Inherit Metab Dis. 1990;13(4):651–657. doi: 10.1007/BF01799520. [DOI] [PubMed] [Google Scholar]
  23. Superti-Furga A., Steinmann B., Duc G., Gitzelmann R. Maternal phenylketonuria syndrome in cousins caused by mild, unrecognized phenylketonuria in their mothers homozygous for the phenylalanine hydroxylase Arg-261-Gln mutation. Eur J Pediatr. 1991 May;150(7):493–497. doi: 10.1007/BF01958431. [DOI] [PubMed] [Google Scholar]
  24. Svensson E., von Döbeln U., Hagenfeldt L. Polymorphic DNA haplotypes at the phenylalanine hydroxylase locus and their relation to phenotype in Swedish phenylketonuria families. Hum Genet. 1991 May;87(1):11–17. doi: 10.1007/BF01213084. [DOI] [PubMed] [Google Scholar]
  25. Tyfield L. A., Meredith A. L., Osborn M. J., Primavesi R., Chambers T. L., Holton J. B., Harper P. S. Genetic analysis of treated and untreated phenylketonuria in one family. J Med Genet. 1990 Sep;27(9):564–568. doi: 10.1136/jmg.27.9.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Tyfield L. A., Osborn M. J., Holton J. B. Molecular heterogeneity at the phenylalanine hydroxylase locus in the population of the south-west of England. J Med Genet. 1991 Apr;28(4):244–247. doi: 10.1136/jmg.28.4.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Waisbren S. E., Levy H. L. Effects of untreated maternal hyperphenylalaninemia on the fetus: further study of families identified by routine cord blood screening. J Pediatr. 1990 Jun;116(6):926–929. doi: 10.1016/s0022-3476(05)80654-7. [DOI] [PubMed] [Google Scholar]
  28. Woo S. L. Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet. 1988 Nov;43(5):781–783. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES